<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury"</p><p>http://www.journal-inflammation.com/content/4/1/18</p><p>Journal of Inflammation (London, England) 2007;4():18-18.</p><p>Published online 20 Sep 2007</p><p>PMCID:PMC2169220.</p><p></p>1 was performed as previously described. Shown are representative micrographs following immunostaining for TGFβ1 in the lung of bleomycin treated, Tr- wild type (A) and Tr+ TGFβ1 transgenic (B) mice. Expression of TGFβ1 is present in both tissue specimens but is substantially enhanced in the Tr+ TGFβ1 transgenic mice. C. Total collagen was determined by hydroxyproline ass...
The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to ...
We previously reported a mouse model for scleroderma by repeated local injections of bleomycin. In t...
Idiopathic pulmonary fibrosis is a progressive, fatal disease with limited treatment options. Protea...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive diffuse disease involving t...
Effective treatments for fibrotic diseases such as idiopathic pulmonary fibrosis are largely lacking...
Thrombospondin-1 (TSP-1) is an extracellular protein critical to normal lung homeostasis, and is rep...
<div><p>The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms rel...
Idiopathic pulmonary fibrosis is a progressive, fatal disease with limited treatment options. Protea...
Effective treatments for fibrotic diseases such as idiopathic pulmonary fibrosis are largely lacking...
Abstract Background Pulmonary fibrosis is a progressive and lethal disease characterized by damage t...
The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to ...
We previously reported a mouse model for scleroderma by repeated local injections of bleomycin. In t...
Idiopathic pulmonary fibrosis is a progressive, fatal disease with limited treatment options. Protea...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
<p><b>Copyright information:</b></p><p>Taken from "Host predisposition by endogenous Transforming Gr...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive diffuse disease involving t...
Effective treatments for fibrotic diseases such as idiopathic pulmonary fibrosis are largely lacking...
Thrombospondin-1 (TSP-1) is an extracellular protein critical to normal lung homeostasis, and is rep...
<div><p>The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms rel...
Idiopathic pulmonary fibrosis is a progressive, fatal disease with limited treatment options. Protea...
Effective treatments for fibrotic diseases such as idiopathic pulmonary fibrosis are largely lacking...
Abstract Background Pulmonary fibrosis is a progressive and lethal disease characterized by damage t...
The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to ...
We previously reported a mouse model for scleroderma by repeated local injections of bleomycin. In t...
Idiopathic pulmonary fibrosis is a progressive, fatal disease with limited treatment options. Protea...